NEW YORK (GenomeWeb) – Qiagen and CareDx announced today that they have signed a deal to combine a Qiagen DNA analysis platform with CareDx's HLA typing kits and interpretation software, and market the combined product to transplant labs.
The firms will put together Qiagen's QIAxcel Advanced automated capillary electrophoresis system and CareDx's Olerup SSP kits and Score software as an additional option for HLA typing processing and data entry for transplant labs.
Financial terms of the deal were not disclosed.
"This collaboration fits well with our strategy to partner with leading innovative solution providers and enhance the transplant lab testing workflow," CareDx Chief International Business Officer Anders Karlsson said in a statement.
Qiagen's head of molecular diagnostics, Thierry Bernard, added that the deal will "allow us to bring our QIAxcel solutions to HLA labs around the globe using the CareDx commercial channel."